Novartis (NVS) announces plans to establish a new radioligand therapy manufacturing site in Denton, Texas
Novartis AG (NYSE:NVS) is one of the top gene therapy stocks to buy according to hedge funds. Novartis AG (NYSE:NVS) announced on February 25 plans to establish a new 46,000-square-foot radioligand therapy manufacturing site in Denton, Texas. It stated...
Insider Monkey